Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
venBio Global Strategic Fund III, L.P. | 10%+ Owner | $322M | Sep 19, 2023 | ||
Redmile Group, LLC | 10%+ Owner | $116M | Sep 19, 2023 | ||
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10%+ Owner | $97.4M | Sep 19, 2023 | ||
Richard A. Heyman | Director | $0 | Feb 26, 2024 | ||
Kenneth Song | PRESIDENT AND CHIEF EXECUTIVE, Director | $0 | Feb 26, 2024 | ||
Viking Global Investors Lp | 10%+ Owner | $0 | Feb 26, 2024 | ||
Maha Katabi | Director | $0 | Feb 26, 2024 | ||
Susan Moran | Chief Medical Officer | $0 | Feb 26, 2024 | ||
Arvind Kush | Chief Financial Officer | $0 | Feb 26, 2024 | ||
Timothy Van Hauwermeiren | Director | Feb 26, 2024 | |||
Aaron Royston | Director | Sep 14, 2023 | |||
Versant Ventures VII GP-GP, LLC | 10%+ Owner | Sep 14, 2023 | |||
Yi Larson | Director | Feb 26, 2024 | |||
Christy J. Oliger | Director | Feb 26, 2024 | |||
Mary Tagliaferri | Director | Feb 26, 2024 | |||
Angie You | Director | Feb 26, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|